Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07146139 · ClinicalTrials.gov registry record · NA
MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women
A NA study, sponsored by Public Health Foundation Enterprises.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT07146139 is a NA study that was terminated before completion, run by Public Health Foundation Enterprises. The registered enrollment target is 2 participants.
The verdict
NCT07146139, a NA study, was terminated before completion, sponsored by Public Health Foundation Enterprises.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.
Interventions
- BEHAVIORAL Standard of Care (SOC)
- DEVICE MyPrEP Plus Package
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-03-18 |
| Est. Completion | 2025-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07146139
The ClinicalTrials.gov registry entry for NCT07146139 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Public Health Foundation Enterprises, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care (SOC) is the first listed.
NCT07146139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07146139 about?
NCT07146139 is a clinical study titled "MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women". The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.
What is the current status of trial NCT07146139?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-03-18. Estimated completion is 2025-03-21.
What interventions are being tested in trial NCT07146139?
The interventions under investigation include: Standard of Care (SOC) (BEHAVIORAL), MyPrEP Plus Package (DEVICE).
Who is sponsoring clinical trial NCT07146139?
This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.